{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:32:59Z","timestamp":1789831979528,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07894"],"award-info":[{"award-number":["20K07894"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00415-024-12295-3","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T06:01:46Z","timestamp":1712210506000},"page":"4067-4074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Takotsubo cardiomyopathy in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"271","author":[{"given":"Atsushi","family":"Terayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4955-1479","authenticated-orcid":false,"given":"Motoi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Samukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikao","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"11","key":"12295_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA et al (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15(11):671\u2013683. https:\/\/doi.org\/10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"12295_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (2014) Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469\u2013482. https:\/\/doi.org\/10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"issue":"Pt 1","key":"12295_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC (2014) Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137(Pt 1):33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285","journal-title":"Brain"},{"issue":"3","key":"12295_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jnnp-2020-325053","volume":"92","author":"S Kusunoki","year":"2021","unstructured":"Kusunoki S, Willison HJ, Jacobs BC (2021) Antiglycolipid antibodies in Guillain-Barr\u00e9 and Fisher syndromes: discovery, current status and future perspective. J Neurol Neurosurg Psychiatry 92(3):311\u2013318. https:\/\/doi.org\/10.1136\/jnnp-2020-325053","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"12295_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J et al (2011) Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29(3):599\u2013612. https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.003","journal-title":"Vaccine"},{"issue":"3","key":"12295_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ahj.2007.11.008","volume":"155","author":"A Prasad","year":"2008","unstructured":"Prasad A, Lerman A, Rihal CS (2008) Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 155(3):408\u2013417. https:\/\/doi.org\/10.1016\/j.ahj.2007.11.008","journal-title":"Am Heart J"},{"issue":"1","key":"12295_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ejhf.424","volume":"18","author":"AR Lyon","year":"2016","unstructured":"Lyon AR, Bossone E, Schneider B et al (2016) Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 18(1):8\u201327. https:\/\/doi.org\/10.1002\/ejhf.424","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"12295_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","volume":"373","author":"C Templin","year":"2015","unstructured":"Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373(10):929\u2013938. https:\/\/doi.org\/10.1056\/NEJMoa1406761","journal-title":"N Engl J Med"},{"issue":"6","key":"12295_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10072-006-0531-0","volume":"26","author":"A Palazzuoli","year":"2006","unstructured":"Palazzuoli A, Lenzi C, Iovine F, Carrera A, Nuti R (2006) A case of acute heart failure associated with Guillain-Barr\u00e9 syndrome. Neurol Sci 26(6):447\u2013450. https:\/\/doi.org\/10.1007\/s10072-006-0531-0","journal-title":"Neurol Sci"},{"issue":"22","key":"12295_CR10","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","volume":"39","author":"JR Ghadri","year":"2018","unstructured":"Ghadri JR, Wittstein IS, Prasad A et al (2018) International expert consensus document on Takotsubo syndrome (part I): Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39(22):2032\u20132046. https:\/\/doi.org\/10.1093\/eurheartj\/ehy076","journal-title":"Eur Heart J"},{"issue":"3","key":"12295_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY et al (1995) Guillain-Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 118(3):597\u2013605. https:\/\/doi.org\/10.1093\/brain\/118.3.597","journal-title":"Brain."},{"issue":"5","key":"12295_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.410350510","volume":"35","author":"S Kusunoki","year":"1994","unstructured":"Kusunoki S, Chiba A, Kon K et al (1994) N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome. Ann Neurol 35(5):570\u2013576. https:\/\/doi.org\/10.1002\/ana.410350510","journal-title":"Ann Neurol"},{"issue":"1","key":"12295_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2169\/internalmedicine1962.24.24","volume":"24","author":"J Ahmad","year":"1985","unstructured":"Ahmad J, Kham AS, Siddiqui MA (1985) Estimation of plasma and urinary catecholamines in Guillain-Barr\u00e9 syndrome. Jpn J Med 24(1):24\u201329. https:\/\/doi.org\/10.2169\/internalmedicine1962.24.24","journal-title":"Jpn J Med"},{"issue":"6","key":"12295_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa043046","volume":"352","author":"IS Wittstein","year":"2005","unstructured":"Wittstein IS, Thiemann DR, Lima JA et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352(6):539\u2013548. https:\/\/doi.org\/10.1056\/NEJMoa043046","journal-title":"N Engl J Med"},{"issue":"Pt 3","key":"12295_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/106.3.589","volume":"106","author":"J Fagius","year":"1983","unstructured":"Fagius J, Wallin BG (1983) Microneurographic evidence of excessive sympathetic outflow in the Guillain-Barr\u00e9 syndrome. Brain 106(Pt 3):589\u2013600. https:\/\/doi.org\/10.1093\/brain\/106.3.589","journal-title":"Brain"},{"issue":"1","key":"12295_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1034\/j.1600-0404.2002.00099.x","volume":"105","author":"M Asahina","year":"2002","unstructured":"Asahina M, Kuwabara S, Suzuki A, Hattori T (2002) Autonomic function in demyelinating and axonal subtypes of Guillain-Barr\u00e9 syndrome. Acta Neurol Scand 105(1):44\u201350. https:\/\/doi.org\/10.1034\/j.1600-0404.2002.00099.x","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"12295_CR17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/mus.20538","volume":"33","author":"Y Kuzumoto","year":"2006","unstructured":"Kuzumoto Y, Shioyama M, Kihara M, Kusunoki S (2006) Abnormal sudomotor axon reflex and antiganglioside antibodies. Muscle Nerve 33(6):828\u2013829. https:\/\/doi.org\/10.1002\/mus.20538","journal-title":"Muscle Nerve"},{"key":"12295_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fneur.2019.00053","volume":"10","author":"T Ziemssen","year":"2019","unstructured":"Ziemssen T, Siepmann T (2019) The investigation of the cardiovascular and sudomotor autonomic nervous system\u2013a review. Front Neurol 10:53. https:\/\/doi.org\/10.3389\/fneur.2019.00053","journal-title":"Front Neurol"},{"issue":"7","key":"12295_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.52.7.857","volume":"52","author":"T Kanda","year":"1989","unstructured":"Kanda T, Hayashi H, Tanabe H, Tsubaki T, Oda M (1989) A fulminant case of Guillain-Barr\u00e9 syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 52(7):857\u2013864. https:\/\/doi.org\/10.1136\/jnnp.52.7.857","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9404","key":"12295_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/s0140-6736(03)15324-x","volume":"363","author":"R van Koningsveld","year":"2004","unstructured":"van Koningsveld R, Schmitz PI, Mech\u00e9 FG, Visser LH, Meulstee J, van Doorn PA, Dutch GBS study group (2004) Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial. Lancet. 363(9404):192\u2013196. https:\/\/doi.org\/10.1016\/s0140-6736(03)15324-x","journal-title":"Lancet."},{"issue":"4","key":"12295_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jns.12234","volume":"22","author":"Y Yamagishi","year":"2017","unstructured":"Yamagishi Y, Suzuki H, Sonoo M et al (2017) Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst 22(4):433\u2013439. https:\/\/doi.org\/10.1111\/jns.12234","journal-title":"J Peripher Nerv Syst"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12295-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12295-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12295-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:25:14Z","timestamp":1720520714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12295-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12295"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12295-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Financial intersts: M. Kuwahara has served as a honoraria speaker for CSL Behring, Japan Blood Product Organization, and Takeda Pharmaceuticals. S. Kusunoki received speech honoraria from Takeda, Japan Blood Product Organization, and CSL Behring and served on the DSMB for Argenx and received consulting fees as a medical expert from KM Biologics. Non-financial intersts: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study conformed with the World Medical Association Declaration of Helsinki and was approved by the Internal Review Board of Kindai University Faculty of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}